rxstatShortages › Daunorubicin

Daunorubicin shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Daunorubicin has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 2
Reports on file
3

Reports by product

Resolved
DAUNORUBICIN HYDROCHLORIDE INJECTION
20MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02539209 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
Resolved
CERUBIDINE 20MG/VIAL
20MG · POWDER FOR SOLUTION · ERFA CANADA 2012 INC
DIN 01926683 · ended Dec 21, 2019 · Disruption of the manufacture of the drug.
Resolved
CERUBIDINE 20MG/VIAL
20MG · POWDER FOR SOLUTION · ERFA CANADA 2012 INC
DIN 01926683 · ended Aug 22, 2019 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Daunorubicin. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Daunorubicin is classified under “CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES” (ATC L01DB).

Recent changes

Common questions

When will Daunorubicin be back in stock in Canada?

Daunorubicin has no active shortage; supply is normal per Health Canada reports.

Why is Daunorubicin in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (cytotoxic antibiotics and related substances)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.